Morales Paula, Hurst Dow P, Reggio Patricia H
Chemistry and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, NC, 27412, USA.
Prog Chem Org Nat Prod. 2017;103:103-131. doi: 10.1007/978-3-319-45541-9_4.
For centuries, hashish and marihuana, both derived from the Indian hemp Cannabis sativa L., have been used for their medicinal, as well as, their psychotropic effects. These effects are associated with the phytocannabinoids which are oxygen containing C aromatic hydrocarbons found in Cannabis sativa L. To date, over 120 phytocannabinoids have been isolated from Cannabis. For many years, it was assumed that the beneficial effects of the phytocannabinoids were mediated by the cannabinoid receptors, CB and CB. However, today we know that the picture is much more complex, with the same phytocannabinoid acting at multiple targets. This contribution focuses on the molecular pharmacology of the phytocannabinoids, including Δ-THC and CBD, from the prospective of the targets at which these important compounds act.
几个世纪以来,源自印度大麻(Cannabis sativa L.)的哈希什和大麻,因其药用及精神作用而被使用。这些作用与植物大麻素有关,植物大麻素是在印度大麻中发现的含氧C芳烃。迄今为止,已从大麻中分离出120多种植物大麻素。多年来,人们一直认为植物大麻素的有益作用是由大麻素受体CB1和CB2介导的。然而,如今我们知道情况要复杂得多,同一种植物大麻素会作用于多个靶点。本论文从这些重要化合物作用靶点的角度,聚焦于植物大麻素的分子药理学,包括Δ⁹-四氢大麻酚(Δ⁹-THC)和大麻二酚(CBD)。